# Carbidopa and Levodopa

NDC: 77771-461
Generic name: Carbidopa and Levodopa
Labeler / Manufacturer: Radha Pharmaceuticals Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20250425

FDA application: ANDA214091

## Active ingredients

- CARBIDOPA: 50 mg/1
- LEVODOPA: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"77771-461"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=77771-461
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=33a22ffe-0d41-162d-e063-6394a90a43d3